CAMBRIDGE, Mass., Feb. 27, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the Cowenand Company 37th Annual Healthcare Conference on Monday, March 6, 2017, at 4:00 p.m. ET in Boston, MA. A live webcast of Infinity's presentation will
About InfinityInfinity is an innovative biopharmaceutical company dedicated to advancing novel medicines for people with cancer. Infinity is advancing IPI-549, an oral immuno-oncology development candidate that selectively inhibits PI3K-gamma. A Phase 1 study in patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.
Contact:Jaren Irene Madden, Senior Director, Investor Relations and Corporate Communications617-453-1336 or Jaren.Madden@infi.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/infinity-to-present-at-37th-annual-cowen-and-company-healthcare-conference-300413327.html
SOURCE Infinity Pharmaceuticals, Inc.
Subscribe to our Free Newsletters!
Chickenpox is a contagious viral infection commonly seen in the younger age group. This quiz looks ...
Summer is a time for fun but the hot weather brings with it a host of diseases. With some health ...
Bacterial infection that causes inflammation of the membranes of the brain, is called bacterial ...View All